Stay updated on Pembrolizumab in NK/T & EBV+ DLBCL: Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in NK/T & EBV+ DLBCL: Clinical Trial page.

Latest updates to the Pembrolizumab in NK/T & EBV+ DLBCL: Clinical Trial page
- ChecktodayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe page’s footer/version label was updated from Revision: v3.5.2 to Revision: v3.5.3, indicating a minor site release change rather than a content change to the clinical trial record.SummaryDifference0.1%

- Check22 days agoChange DetectedAdded Revision: v3.5.2 and removed Revision: v3.5.0.SummaryDifference0.1%

- Check51 days agoChange DetectedPage revision updated to v3.5.0; the previous revision v3.4.3 has been removed.SummaryDifference0.1%

- Check66 days agoChange DetectedRevision updated to v3.4.3, replacing the previous revision v3.4.2.SummaryDifference0.1%

- Check87 days agoChange DetectedThe page shows a minor revision update (Revision: v3.4.2 added; Revision: v3.4.1 removed) and no changes to study details or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check95 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1; this is a minor site maintenance update that does not affect study content or user-facing features. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab in NK/T & EBV+ DLBCL: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in NK/T & EBV+ DLBCL: Clinical Trial page.